177 related articles for article (PubMed ID: 36940052)
1. Poor Karnofsky performance status is not a contraindication for neurosurgical resection in patients with lung cancer brain metastases: a multicenter, retrospective PSM-IPTW cohort study.
Liang L; Wen L; Qin S; He Z; Lu J; Cui R; Jiang X; Hu H; Zhong S; Li C; Yu C; Xie Y; Wang Z; Duan H; Mou Y
J Neurooncol; 2023 Apr; 162(2):327-335. PubMed ID: 36940052
[TBL] [Abstract][Full Text] [Related]
2. Survival Benefit from Surgical Resection in Lung Cancer Patients with Brain Metastases: a Single-Center, Propensity-Matched Analysis Cohort Study.
Wang ZN; Jiang XB; Lu J; Guo XY; He ZQ; Duan H; Liang L; Cui R; Hu HR; Zhang XH; Zhong S; Li C; Yu CW; Guo CC; Mou YG
Ann Surg Oncol; 2022 Jun; 29(6):3684-3693. PubMed ID: 35181815
[TBL] [Abstract][Full Text] [Related]
3. Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching study.
Chen Q; Zhang R; Xing B; Li C; Xiu D; Chen J; Deng Y; Chen X; Guo R; Chen F; Peng J; Sun T; Wang H; Li M; Zheng Q; Bi X; Zhao J; Zhou J; Li Z; Huang Z; Zhang Y; Zhang Y; Cai J; Zhao H
Int J Surg; 2022 Oct; 106():106952. PubMed ID: 36220519
[TBL] [Abstract][Full Text] [Related]
4. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
5. Enhancing outcomes: neurosurgical resection in brain metastasis patients with poor Karnofsky performance score - a comprehensive survival analysis.
Goldberg M; Mondragon-Soto MG; Altawalbeh G; Baumgart L; Gempt J; Bernhardt D; Combs SE; Meyer B; Aftahy AK
Front Oncol; 2023; 13():1343500. PubMed ID: 38269027
[TBL] [Abstract][Full Text] [Related]
6. Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.
Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hoerner-Rieber J; König L; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
J Neurooncol; 2017 Aug; 134(1):205-212. PubMed ID: 28560661
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
[TBL] [Abstract][Full Text] [Related]
8. Survival benefit from immunocheckpoint inhibitors in stage IV non-small cell lung cancer patients with brain metastases: A National Cancer Database propensity-matched analysis.
Takamori S; Komiya T; Powell E
Cancer Med; 2021 Feb; 10(3):923-932. PubMed ID: 33340271
[TBL] [Abstract][Full Text] [Related]
9. An elevated preoperative cholesterol-to-lymphocyte ratio predicts unfavourable outcomes in colorectal cancer liver metastasis patients receiving simultaneous resections: a retrospective study.
Deng Y; Chen Q; Chen J; Zhang Y; Zhao J; Bi X; Li Z; Zhang Y; Huang Z; Cai J; Zhao H
BMC Surg; 2023 May; 23(1):131. PubMed ID: 37194000
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
11. Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study.
Gerritsen JKW; Zwarthoed RH; Kilgallon JL; Nawabi NL; Jessurun CAC; Versyck G; Pruijn KP; Fisher FL; Larivière E; Solie L; Mekary RA; Satoer DD; Schouten JW; Bos EM; Kloet A; Nandoe Tewarie R; Smith TR; Dirven CMF; De Vleeschouwer S; Broekman MLD; Vincent AJPE
Lancet Oncol; 2022 Jun; 23(6):802-817. PubMed ID: 35569489
[TBL] [Abstract][Full Text] [Related]
12. Brain Metastases of Non-Small Cell Lung Cancer: Prognostic Factors in Patients with Surgical Resection.
Antuña AR; Vega MA; Sanchez CR; Fernandez VM
J Neurol Surg A Cent Eur Neurosurg; 2018 Mar; 79(2):101-107. PubMed ID: 28586934
[TBL] [Abstract][Full Text] [Related]
13. Survival Benefits of Radiotherapy and Surgery in Lung Cancer Brain Metastases with Poor Prognosis Factors.
Liang L; Wang Z; Duan H; He Z; Lu J; Jiang X; Hu H; Li C; Yu C; Zhong S; Cui R; Guo X; Deng M; Chen Y; Du X; Wu S; Chen L; Mou Y
Curr Oncol; 2023 Feb; 30(2):2227-2236. PubMed ID: 36826133
[TBL] [Abstract][Full Text] [Related]
14. Mortality, Morbidity, and Prognostic Factors in the Surgical Resection of Brain Metastases: A Contemporary Cohort Study.
Picarelli H; Oliveira ML; Marta GN; Solla DJF; Teixeira MJ; Figueiredo EG
J Neurol Surg A Cent Eur Neurosurg; 2020 Jul; 81(4):279-289. PubMed ID: 32107755
[TBL] [Abstract][Full Text] [Related]
15. The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.
Goldman DA; Hovinga K; Reiner AS; Esquenazi Y; Tabar V; Panageas KS
J Neurosurg; 2018 Nov; 129(5):1231-1239. PubMed ID: 29303449
[TBL] [Abstract][Full Text] [Related]
16. Epidermal Growth Factor Receptor Mutation Status Confers Survival Benefit in Patients with Non-Small-Cell Lung Cancer Undergoing Surgical Resection of Brain Metastases: A Retrospective Cohort Study.
Huang Y; Chow KKH; Aredo JV; Padda SK; Han SS; Kakusa BW; Hayden Gephart M
World Neurosurg; 2019 May; 125():e487-e496. PubMed ID: 30710723
[TBL] [Abstract][Full Text] [Related]
17. Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients.
Lehrer EJ; Ahluwalia MS; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Fakhoury KR; Rusthoven CG; Mathieu D; Trudel C; Malouff TD; Ruiz-Garcia H; Bonney P; Hwang L; Yu C; Zada G; Patel S; Deibert CP; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Jones BM; Green S; Sheehan JP; Trifiletti DM
J Neurosurg; 2023 May; 138(5):1178-1187. PubMed ID: 36115055
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and long-term survival in surgically treated brain metastases from non-small cell lung cancer.
Enders F; Geisenberger C; Jungk C; Bermejo JL; Warta R; von Deimling A; Herold-Mende C; Unterberg A
Clin Neurol Neurosurg; 2016 Mar; 142():72-80. PubMed ID: 26816105
[TBL] [Abstract][Full Text] [Related]
19. Generation of a New Disease-specific Prognostic Score for Patients With Brain Metastases From Small-cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS-Score) and Validation of Two Other Indices.
Bernhardt D; König L; Aufderstrasse S; Krisam J; Hoerner-Rieber J; Adeberg S; Bozorgmehr F; El Shafie R; Lang K; Kappes J; Thomas M; Herth F; Heußel CP; Warth A; Marcrom S; Debus J; Steins M; Rieken S
Clin Lung Cancer; 2018 Jul; 19(4):340-345. PubMed ID: 29373273
[TBL] [Abstract][Full Text] [Related]
20. Perioperative outcomes and survival in elderly patients aged ≥ 75 years undergoing gastrectomy for gastric cancer: an 18-year retrospective analysis in a single Western centre.
Tan E; Lam S; Han SP; Storey D; Sandroussi C
Langenbecks Arch Surg; 2021 Jun; 406(4):1057-1069. PubMed ID: 33770264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
